Simultaneous analysis of five genetic risk factors in Polish patients with Alzheimer's disease.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 12782337)

Published in Neurosci Lett on June 26, 2003

Authors

Maria Styczynska1, Dorota Religa, Anna Pfeffer, Elzbieta Luczywek, Boguslaw Wasiak, Grzegorz Styczynski, Beata Peplonska, Tomasz Gabryelewicz, Marek Golebiowski, Malgorzata Kobrys, Maria Barcikowska

Author Affiliations

1: Department of Neurodegenerative Disorders, Medical Research Centre, Polish Academy of Sciences, 5 Pawinskiego Str., 02-106 Warsaw, Poland. desperat@cmdik.pan.pl

Articles by these authors

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1). Nat Genet (2009) 8.39

A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30

Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54

Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev (2007) 4.23

Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69

Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 2.72

Tobacco smoking, NAT2 acetylation genotype and breast cancer risk. Int J Cancer (2006) 2.31

The use of cholinesterase inhibitors and the risk of myocardial infarction and death: a nationwide cohort study in subjects with Alzheimer's disease. Eur Heart J (2013) 2.15

Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum Genet (2006) 2.02

Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92

TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson's disease. Mol Neurodegener (2013) 1.83

Considerations of circadian impact for defining 'shift work' in cancer studies: IARC Working Group Report. Occup Environ Med (2010) 1.60

Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59

Endometrial cancer and genetic variation in PTEN, PIK3CA, AKT1, MLH1, and MSH2 within a population-based case-control study. Gynecol Oncol (2010) 1.47

Association between genetic and environmental factors and the risk of Alzheimer's disease. Folia Neuropathol (2008) 1.46

Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol Biomarkers Prev (2006) 1.34

Genetic variation of Omi/HtrA2 and Parkinson's disease. Parkinsonism Relat Disord (2008) 1.34

Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: a population-based analysis. Int J Cancer (2007) 1.31

Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29

Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions. Cancer Causes Control (2007) 1.28

Genetic polymorphisms in the one-carbon metabolism pathway and breast cancer risk: a population-based case-control study and meta-analyses. Int J Cancer (2007) 1.28

Ovarian cancer risk and common variation in the sex hormone-binding globulin gene: a population-based case-control study. BMC Cancer (2007) 1.27

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 1.26

Hormonal markers in breast cancer: coexpression, relationship with pathologic characteristics, and risk factor associations in a population-based study. Cancer Res (2007) 1.22

Sigma nonopioid intracellular receptor 1 mutations cause frontotemporal lobar degeneration-motor neuron disease. Ann Neurol (2010) 1.21

Expression of TGF-beta signaling factors in invasive breast cancers: relationships with age at diagnosis and tumor characteristics. Breast Cancer Res Treat (2009) 1.20

Analysis of terminal duct lobular unit involution in luminal A and basal breast cancers. Breast Cancer Res (2012) 1.16

Dilated inferior vena cava in young adults with vasovagal syncope. Arch Intern Med (2009) 1.16

Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J (2005) 1.12

Agraphia in patients with frontotemporal dementia and parkinsonism linked to chromosome 17 with P301L MAPT mutation: dysexecutive, aphasic, apraxic or spatial phenomenon? Neurocase (2012) 1.12

Common genetic variation in TP53 and its flanking genes, WDR79 and ATP1B2, and susceptibility to breast cancer. Int J Cancer (2007) 1.12

Genetic variation in tumor necrosis factor and lymphotoxin-alpha (TNF-LTA) and breast cancer risk. Hum Genet (2007) 1.10

Genetic variation in CYP17 and endometrial cancer risk. Hum Genet (2008) 1.09

The ATM missense mutation p.Ser49Cys (c.146C>G) and the risk of breast cancer. Hum Mutat (2006) 1.09

Mitochondrial haplogroup H and Alzheimer's disease--is there a connection? Neurobiol Aging (2008) 1.07

Differences in drug therapy between dementia disorders in the Swedish dementia registry: a nationwide study of over 7,000 patients. Dement Geriatr Cogn Disord (2013) 1.07

Replication of BIN1 association with Alzheimer's disease and evaluation of genetic interactions. J Alzheimers Dis (2011) 1.07

Common genetic variation in the sex hormone metabolic pathway and endometrial cancer risk: pathway-based evaluation of candidate genes. Carcinogenesis (2010) 1.07

DNA hypermethylation of ESR1 and PGR in breast cancer: pathologic and epidemiologic associations. Cancer Epidemiol Biomarkers Prev (2009) 1.04

GWAS risk factors in Parkinson's disease: LRRK2 coding variation and genetic interaction with PARK16. Am J Neurodegener Dis (2013) 1.03

Glutathione S-transferase omega genes in Alzheimer and Parkinson disease risk, age-at-diagnosis and brain gene expression: an association study with mechanistic implications. Mol Neurodegener (2012) 1.02

Replication of EPHA1 and CD33 associations with late-onset Alzheimer's disease: a multi-centre case-control study. Mol Neurodegener (2011) 1.01

Genetic variation in SIPA1 in relation to breast cancer risk and survival after breast cancer diagnosis. Int J Cancer (2009) 0.98

TOMM40 rs10524523 polymorphism's role in late-onset Alzheimer's disease and in longevity. J Alzheimers Dis (2012) 0.97

Two novel presenilin 1 gene mutations connected with frontotemporal dementia-like clinical phenotype: genetic and bioinformatic assessment. Exp Neurol (2006) 0.97

Mutations in presenilin 1, presenilin 2 and amyloid precursor protein genes in patients with early-onset Alzheimer's disease in Poland. Exp Neurol (2003) 0.97

Discrimination of benign from malignant hepatic lesions based on their T2-relaxation times calculated from moderately T2-weighted turbo SE sequence. Eur Radiol (2002) 0.96

Mitochondrial DNA haplogroups and subhaplogroups are associated with Parkinson's disease risk in a Polish PD cohort. J Neural Transm (Vienna) (2008) 0.96

Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev (2007) 0.94

Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women. Pharmacogenet Genomics (2006) 0.93

Association study of cholesterol-related genes in Alzheimer's disease. Neurogenetics (2007) 0.92

VEGF significantly restores impaired memory behavior in Alzheimer's mice by improvement of vascular survival. Sci Rep (2013) 0.91

Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome. Chest (2012) 0.91

Strong association between Saitohin gene polymorphism and tau haplotype in the Polish population. Neurosci Lett (2003) 0.90

A multi-centre clinico-genetic analysis of the VPS35 gene in Parkinson disease indicates reduced penetrance for disease-associated variants. J Med Genet (2012) 0.90

Intrauterine environment and breast cancer risk in a population-based case-control study in Poland. Int J Cancer (2006) 0.89

Accelerometer-based measures of active and sedentary behavior in relation to breast cancer risk. Breast Cancer Res Treat (2012) 0.89

Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk. Cancer Res (2006) 0.89

Active and passive cigarette smoking and the risk of endometrial cancer in Poland. Eur J Cancer (2009) 0.87

Costs of diagnosing dementia: results from SveDem, the Swedish Dementia Registry. Int J Geriatr Psychiatry (2013) 0.87

Intake of fruits, and vegetables in relation to breast cancer risk by hormone receptor status. Breast Cancer Res Treat (2007) 0.87

Polish Centenarians Programme. Multidisciplinary studies of successful ageing: aims, methods, and preliminary results. Exp Gerontol (2007) 0.87

No association between FTO or HHEX and endometrial cancer risk. Cancer Epidemiol Biomarkers Prev (2010) 0.87

PIN1 gene variants in Alzheimer's disease. BMC Med Genet (2009) 0.86

Variation in NPC1, the gene encoding Niemann-Pick C1, a protein involved in intracellular cholesterol transport, is associated with Alzheimer disease and/or aging in the Polish population. Neurosci Lett (2008) 0.86

A high red blood cell distribution width predicts failure of arteriovenous fistula. PLoS One (2012) 0.85

Human leukocyte antigen variation and Parkinson's disease. Parkinsonism Relat Disord (2011) 0.85

N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI). Med Sci Monit (2011) 0.85

Plasma beta amyloid and cytokine profile in women with Alzheimer's disease. Neuro Endocrinol Lett (2008) 0.85

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease. CNS Neurosci Ther (2010) 0.85

Conformational altered p53 as an early marker of oxidative stress in Alzheimer's disease. PLoS One (2012) 0.85

Analysis of serum metabolic profiles in women with endometrial cancer and controls in a population-based case-control study. J Clin Endocrinol Metab (2012) 0.85

A patient with posterior cortical atrophy possesses a novel mutation in the presenilin 1 gene. PLoS One (2013) 0.84

Field comparison of inhalable aerosol samplers applied in the european rubber manufacturing industry. Int Arch Occup Environ Health (2006) 0.83

Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes. J Alzheimers Dis (2009) 0.83

Mutation screening of the MAPT and STH genes in Polish patients with clinically diagnosed frontotemporal dementia. Dement Geriatr Cogn Disord (2003) 0.83

MR spectroscopy in monitoring the treatment of Wilson's disease patients. Mov Disord (2008) 0.83

Genetic variation in PRL and PRLR, and relationships with serum prolactin levels and breast cancer risk: results from a population-based case-control study in Poland. Breast Cancer Res (2011) 0.83

Automated oscillometric measurement of the ankle-brachial index in patients with coronary artery disease. Hypertens Res (2012) 0.83

Intra-familial clinical heterogeneity due to FTLD-U with TDP-43 proteinopathy caused by a novel deletion in progranulin gene (PGRN). J Alzheimers Dis (2010) 0.83

Sigma receptor type 1 gene variation in a group of Polish patients with Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2007) 0.82